Fotios Koumpouras is a Rheumatology/Immunology physician affiliated with Yale University. OpenAlex indexes 42 publications with 731 citations (h-index 12).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
6 Devine St
Suite 2b
North Haven, CT 064732195
Telephone
203-737-5430Registry record last updated 30 Jun 2015.
Industry payments
7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year202526 payments$28,237openpaymentsdata.cms.gov ↗
- GlaxoSmithKline, LLC.Program year20251 payment
- ABBVIE INC.Program year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
32%Folate Analog Metabolic Inhibitor13.7%Methotrexate68%Methotrexate Sodium16%Rasuvo16%Part D<11 patientsJAK inhibitor6.1%Rinvoq76%Xeljanz Xr24%Part D<11 patients+ 5 more classes in this area
Metabolism & gastrointestinal
19.5%Corticosteroid12.4%Prednisone100%Part D≥41 patientsH2 blocker3%Famotidine100%Part D<11 patients+ 3 more classes in this area
Nervous system
17%Gabapentinoids6.4%Gabapentin58%Pregabalin42%Part D<11 patientsOpioid Agonist5.5%Tramadol Hcl100%Part D≥11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Lupus Immune Complexes Drive Distinct Pro-Inflammatory Monocyte and Macrophage Populations Independent of Type I Interferon
bioRxiv (Cold Spring Harbor Laboratory)
2026 - Outcomes following single level posterior lumbar fusion in patients with systemic and discoid lupus: A retrospective national database study
North American Spine Society Journal (NASSJ)
2025 - Cutaneous Lupus Features Specialized Stromal Niches and Altered Retroelement Expression
Journal of Investigative Dermatology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
John Krystal, MD
Yale University
Lajos Pusztai, MD
Yale University
Lee Schwamm, MD
Yale University
Thomas McGlashan, MD
Yale University
David Felson, MD
Boston University
Marc Hochberg, MD
University of Maryland School of Medicine
Philip Mease, MD
Michelle Petri, MD
Johns Hopkins University School of Medicine
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”